Neogen Ionics & Morita Investment JV for Electrolyte Salt Production
Neogen Ionics partners with Japan's Morita Investment to produce Electrolyte Salt in India, forming a joint venture with NIL holding 80% stake and MIL holding 20% with a $20 million investment.
The joint venture marks a significant strategic move for Neogen Chemicals, positioning them in the rapidly growing Lithium-Ion Battery market and supporting domestic value addition.
The joint venture is expected to benefit Neogen Chemicals through enhanced efficiency, cost competitiveness, and accelerated access to international markets.
* Neogen Ionics (NIL), a Neogen Chemicals subsidiary, has formed a joint venture with Morita Investment Limited (MIL) of Japan. * NIL holds 80% stake in Neogen Morita New Materials Limited (NML), while MIL holds 20% with a $20 million (₹166 crore) investment. * NML will produce LiPF6 salt for Lithium-Ion batteries. * The JV aims to diversify the supply chain from China, leveraging Japanese technology in India. * This collaboration supports the 'Aatmanirbhar Bharat' vision. * NIL will benefit from Morita Group’s technology for electrolyte salt production and access to international markets. * The construction of land acquired in Pakhajan, Dahej PCPIR, Gujarat dedicated for projects related to battery materials is expected to start during 2026.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under joint ventures. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.